---
title: "\"Performance\" Hengchang Group's annual loss narrowed to 21.76 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259212100.md"
description: "PROSP GP INTL announced its financial results for the fiscal year ending in June, with revenue recorded at HKD 143 million, a year-on-year decrease of 11.1%. The loss narrowed from HKD 47.26 million in the previous year to HKD 21.76 million, with a loss per share of 15.5 cents. No dividend was declared"
datetime: "2025-09-28T10:38:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259212100.md)
  - [en](https://longbridge.com/en/news/259212100.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259212100.md)
---

# "Performance" Hengchang Group's annual loss narrowed to 21.76 million yuan

PROSP GP INTL (01421.HK) announced its financial results for the fiscal year ending in June, with revenue recorded at HKD 143 million, a year-on-year decrease of 11.1%. The loss narrowed from HKD 47.26 million in the previous year to HKD 21.76 million, with a loss per share of 15.5 cents. No dividend was declared

### Related Stocks

- [02941.HK](https://longbridge.com/en/quote/02941.HK.md)
- [01421.HK](https://longbridge.com/en/quote/01421.HK.md)

## Related News & Research

- [Revival Gold Expands Drilling Program After Intersecting 6.4 G/T Gold Over 19 Meters At Beartrack-Arnett | RVLGF Stock News](https://longbridge.com/en/news/283344387.md)
- [Revelar Capital-Backed Steele Solutions Acquires Maysteel Industries](https://longbridge.com/en/news/283364237.md)
- [ZAWYA: The Private Standard rebrands to reflect expanded focus on private offices](https://longbridge.com/en/news/283449582.md)
- [01:28 ETFirst Mold Announces Moderate Price Adjustment Amid Global Chemical Raw Material Surge](https://longbridge.com/en/news/283442259.md)
- [Fusen Pharmaceutical Wins China Approval for Glucosamine Osteoarthritis Capsule](https://longbridge.com/en/news/283163403.md)